New and emerging biologic therapies for moderate‐to‐severe plaque psoriasis: mechanistic rationales and recent clinical data for IL ‐17 and IL ‐23 inhibitors
Author:
Affiliation:
1. Department of DermatologyUniversity of Maryland Medical CenterBaltimore Maryland
2. Department of DermatologyUniversity of Texas Health Science CenterHouston Texas
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12251
Reference45 articles.
1. Definition of treatment goals for moderate to severe psoriasis: a European consensus
2. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update
3. National Institute for Health and Clinical Excellence. Psoriasis: The assessment and management of psoriasis. NICE clinical guideline 153.2012. Available at:http://www.nice.org.uk/guidance/cg153/resources/guidance‐psoriasis‐pdf. Accessed February 13 2015.
4. European S3-Guidelines on the systemic treatment of psoriasis vulgaris
5. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk of candidiasis associated with interleukin-17 inhibitors: implications and management;Mycology;2023-10-20
2. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds;Cells;2023-06-20
3. Erythema Dyschromicum Perstans After Adalimumab Treatment;Cureus;2022-12-06
4. Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors – brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry;Journal of Dermatological Treatment;2022-05-29
5. Oral Candida Infection in Psoriatic Patients Treated with IL17A Inhibitors: Report of 3 Cases and a Comprehensive Review of the Literature;Diagnostics;2021-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3